Validose

New York, United States

Validose delivers unique medication adherence solutions to improve clinical trial outcomes

$1.6M raised

Jan 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Validose raised?

Validose has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in January 2025.

Who are Validose's investors?

Validose's investors include 10XBeta, Peter Bauer’s Family Office, Interstate Fusion Ventures.

Where is Validose headquartered?

Validose is headquartered in New York, United States.

What does Validose do?

Validose delivers unique medication adherence solutions to improve clinical trial outcomes

What stage is Validose at?

Validose is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 6, 2025.

MLA

"Validose — Funding & Investors." VCBacked, January 6, 2025, https://www.vcbacked.co/company/validose. Accessed July 4, 2026.

APA

VCBacked. (2025). Validose — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/validose

Wikipedia (cite web)

{{cite web |title=Validose — Funding & Investors |url=https://www.vcbacked.co/company/validose |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 6, 2025.